News

Interim Results for the six months ended 30 June 2008
26 September 2008

TyraTech Inc. (AIM: TYR), a leading independent novel pesticide company for human, animal and environmental health, today announces its interim results for the six month period ended 30 June 2008.

Download

The full results are available to download in PDF format.


Operational Highlights:

Financial Highlights:

Post Period highlights:

Commenting on the interim results Douglas Armstrong PhD, Chief Executive Officer of TyraTech, said: “Throughout the period we have made good progress with transitioning our core technologies into revenue generating programmes and products.  Sales have been modest but are steadily increasing for our lead institutional product and we have continued to diversify our business model in an attempt to provide access to multiple revenue streams.  Our partnerships with both prospective parties and for existing programmes are progressing very well.  However, as we have pushed forward successfully to gain entry into certain new markets, we have experienced lower than originally targeted rates of initial return.” 

“Although market entry and adoption has been slower than we originally expected, we remain positive that our business strategy of revenue growth as well as new potential partnerships, will now start to show increased traction and strength. We expect to report an improvement in revenues in H2 2008 and strong growth in 2009. In addition, we look forward to updating investors on expected progress from new partnering and licensing deals plus strong additional news flow over the coming months.”

 

For further information please contact:

TyraTech Inc.
Alan Reade, Executive Chairman
www.tyratech.com

1 (321) 409 - 7720
Nomura Code Securities
Charles Walker
www.nomuracode.com
+44 (0)20 7776 1200
Buchanan Communications
Mary-Jane Johnson/Lisa Baderoon/Catherine Breen
www.buchanan.uk.com
+44 (0) 20 7466 5000

 

 

<< Back to News releases

Disclaimer for U.S. Site Visitors

This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.